Tandingan, Dolores A.
HRN: 25-81-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/07/2024
09/14/2024
IV
2.25g
Q8H
Non-healing Wound, Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes